PDF (4.5 MB)
Collect
Submit Manuscript
Article | Open Access

Exploring the material basis and mechanism of Moringa oleifera in alleviating slow transit constipation based on network pharmacology and animal models

Sijin Lia,b,1Xiaoyu Gaoa,b,1Kaifeng Guob,cShuangfeng Liub,cWeiqian Yangb,cYan ZhaodJun Shengc()Zhongbin Baie()Yang Tiana,b,c()
Yunnan Key Laboratory of Precision Nutrition and Personalized Food Manufacturing, Yunnan Agricultural University, Kunming 650500, China
College of Food Science and Technology, Yunnan Agricultural University, Kunming 650500, China
Engineering Research Center of Development and Utilization of Food and Drug Homologous Resources, Ministry of Education, Yunnan Agricultural University, Kunming 650201, China
Department of Science and Technology, Yunnan Agricultural University, Kunming 650201, China
College of Veterinary Medicine, Yunnan Agricultural University, Kunming 650201, China

1 These authors have contributed equally to this work.

Peer review under responsibility of Beijing Academy of Food Sciences.

Show Author Information

Highlights

• The active part of M. oleifera in promoting defecation is ASP, not APP.

• It was found for the first time that Phe is the key active composition of M. oleifera leaves.

• Phe can relieve constipation by regulating key nodes in the GPCR-MLC signaling pathway.

Graphical Abstract

View original image Download original image

Abstract

Moringa oleifera have laxative effects, but their active compositions and mechanisms are not very clear thus far. To this end, we systematically explored the active components and mechanism of M. oleifera leaves in relieving constipation by using the slow transit constipation (STC) mouse model and network pharmacology. The results of animal experiments showed that M. oleifera aqueous extract (MOA) had good laxative activity, and its 70% alcohol soluble part (ASP) also showed significant laxative activity (P < 0.01). Network pharmacological prediction results suggested that L-phenylalanine (Phe) was the key compound of ASP, and it might relieve constipation through tachykinin receptor 1 (TACR1) and three kinds of adrenergic receptors, including α1A (ADRA1A), α2A (ADRA2A), and α2B (ADRA2B). Further animal experiment results showed that Phe significantly promoted gastrointestinal motility. Phe may relieve STC by enhancing the release of substance P (SP) and upregulating the mRNA expression of TACR1 in the ileum. Importantly, Phe may also promote intestinal movement by downregulating the mRNA expression of ADRA2A and ADRA2B and upregulating the mRNA expression of Calm and the mRNA and protein expression of myosin light chain 9 in the ileum, thereby activating the G protein-coupled receptor-myosin light chain signaling pathway. These results lay a foundation for the application of M. oleifera and Phe in constipation.

Electronic Supplementary Material

Download File(s)
fshw-14-3-9250059_ESM.doc (11.8 MB)

References

[1]

L.R. Schiller, Chronic constipation: new insights, better outcomes? Lancet Gastroenterol. Hepatol. 4 (2019) 873-882. https://doi.org/10.1016/S2468-1253(19)30199-2.

[2]

M.H. Vriesman, I.J.N. Koppen, M. Camilleri, et al., Management of functional constipation in children and adults, Nat. Rev. Gastroenterol. Hepatol. 17 (2020) 21-39. https://doi.org/10.1038/s41575-019-0222-y.

[3]

A.E. Bharucha, B.E. Lacy, Mechanisms, evaluation, and management of chronic constipation, Gastroenterology 158 (2020) 1232-1249.e3. https://doi.org/10.1053/j.gastro.2019.12.034.

[4]

I. Aziz, W.E. Whitehead, O.S. Palsson, et al., An approach to the diagnosis and management of Rome Ⅳ functional disorders of chronic constipation, Expert Rev. Gastroenterol. Hepatol. 14 (2020) 39-46. https://doi.org/10.1080/17474124.2020.1708718.

[5]

L.A. Harris, C.H. Chang, Burden of constipation: looking beyond bowel movements, Am. J. Gastroenterol. 117 (2022) S2-S5. https://doi.org/10.14309/ajg.0000000000001708.

[6]

A.E. Bharucha, A. Wald, Chronic constipation, Mayo Clin. Proc. 94 (2019) 2340-2357. https://doi.org/10.1016/j.mayocp.2019.01.031.

[7]

K. Sadler, F. Arnold, S. Dean, Chronic constipation in adults, Am. Fam. Physician 106 (2022) 299-306.

[8]

B. Waclawiková, P. Cesar Telles de Souza, M. Schwalbe, et al., Potential binding modes of the gut bacterial metabolite, 5-hydroxyindole, to the intestinal L-type calcium channels and its impact on the microbiota in rats, Gut Microbes 15 (2023) 2154544. https://doi.org/10.1080/19490976.2022.2154544.

[9]

Q. Wang, F. Shen, J. Zhang, et al., Consumption of wheat peptides improves functional constipation: a translational study in humans and mice, Mol. Nutr. Food Res. 66 (2022) e2200313. https://doi.org/10.1002/mnfr.202200313.

[10]

J.Q. He, M.L. Wang, L.C. Yang, et al., Astragaloside Ⅳ alleviates intestinal barrier dysfunction via the AKT-GSK3β-β-catenin pathway in peritoneal dialysis, Front. Pharmacol. 13 (2022) 873150. https://doi.org/10.3389/fphar.2022.873150.

[11]

S.H. Han, K. Park, E.Y. Kim, et al., Cactus (Opuntia humifusa) water extract ameliorates loperamide-induced constipation in rats, BMC Complement. Altern. Med. 17 (2017) 49. https://doi.org/10.1186/s12906-016-1552-8.

[12]

X.J. Liu, H.L. Liu, F.X. Wei, et al., Fecal metabolomics and network pharmacology reveal the correlations between constipation and depression, J. Proteome Res. 20 (2021) 4771-4786. https://doi.org/10.1021/acs.jproteome.1c00435.

[13]

Z.W. Yao, S.Q. Fu, B.B Ren, et al., Based on network pharmacology and gut microbiota analysis to investigate the mechanism of the laxative effect of pterostilbene on loperamide-induced slow transit constipation in mice, Front. Pharmacol. 13 (2022) 913420. https://doi.org/10.3389/fphar.2022.913420.

[14]

S.S.C. Rao, D.M. Brenner. Efficacy and safety of over-the-counter therapies for chronic cconstipation: an updated systematic review, Am. J. Gastroenterol. 116 (2021) 1156-1181. https://doi.org/10.14309/ajg.0000000000001222.

[15]

K. Krogh, G. Chiarioni, W. Whitehead, Management of chronic constipation in adults, United Eur. Gastroenterol. J. 5 (2017) 465-472. https://doi.org/10.1177/2050640616663439.

[16]

M.A. Hassan, T. Xu, Y. Tian, et al., Health benefits and phenolic compounds of Moringa oleifera leaves: a comprehensive review, Phytomedicine 93 (2021) 153771. https://doi.org/10.1016/j.phymed.2021.153771.

[17]

C. Li, Z.Y. Li, H.W. Wu, et al., Therapeutic effect of Moringa oleifera leaves on constipation mice based on pharmacodynamics and serum metabonomics, J. Ethnopharmacol. 282 (2022) 114644. https://doi.org/10.1016/j.jep.2021.114644.

[18]

A. Senthilkumar, N. Karuvantevida, L. Rastrelli, et al., Traditional uses, pharmacological efficacy, and phytochemistry of Moringa peregrina (Forssk.) Fiori: a review, Front. Pharmacol. 9 (2018) 465. https://doi.org/10.3389/fphar.2018.00465.

[19]

M.Y. Jiang, H. Lu, X.Y. Pu, et al., Laxative metabolites from the leaves of Moringa oleifera, J. Agric. Food Chem. 68 (2020) 7850-7860. https://doi.org/10.1021/acs.jafc.0c01564.

[20]

X.Y. Gao, Y.F. Hu, Y.F. Tao, et al., Cymbopogon citratus (DC.) stapf aqueous extract ameliorates loperamide-induced constipation in mice by promoting gastrointestinal motility and regulating the gut microbiota, Front. Microbiol. 13 (2022) 1017804. https://doi.org/10.3389/fmicb.2022.1017804.

[21]

L. Wu, L.M. Gao, X. Jin, et al., Ethanol extract of mao jian green tea attenuates gastrointestinal symptoms in a rat model of irritable bowel syndrome with constipation via the 5-hydroxytryptamine signaling pathway, Foods 12 (2023) 1101. https://doi.org/10.3390/foods12051101.

[22]

K. Naitou, H. Iwashita, H.H. Ueda, et al., Intrathecally administered substance P activated the spinal defecation center and enhanced colorectal motility in anesthetized rats, Am. J. Physiol. Gastrointest. Liver Physiol. 323 (2022) G21-G30. https://doi.org/10.1152/ajpgi.00342.2021.

[23]

C.A. Moreno, N. Sobreira, E. Pugh, et al., Homozygous deletion in MYL9 expands the molecular basis of megacystis-microcolon-intestinal hypoperistalsis syndrome, Eur. J. Hum. Genet. 26 (2018) 669-675. https://doi.org/10.1038/s41431-017-0055-5.

[24]

J. Sun, Y.N. Qiao, T. Tao, et al., Distinct roles of smooth muscle and non-muscle myosin light chain-mediated smooth muscle contraction, Front. Physiol. 11 (2020) 593966. https://doi.org/10.3389/fphys.2020.593966.

[25]

M. Kurahashi, Y. Kito, M. Hara, et al., Norepinephrine has dual effects on human colonic contractions through distinct subtypes of α1 adrenoceptors, Cell. Mol. Gastroenterol. Hepatol. 10 (2020) 658-671.e1. https://doi.org/10.1016/j.jcmgh.2020.04.015.

[26]

X.T. Zhang, K. Yoshihara, N. Miyata, et al., Dietary tryptophan, tyrosine, and phenylalanine depletion induce reduced food intake and behavioral alterations in mice, Physiol. Behav. 244 (2022) 113653. https://doi.org/10.1016/j.physbeh.2021.113653.

[27]

B. Hanson, S.M. Siddique, Y. Scarlett, et al., American gastroenterological association institute technical review on the medical management of opioid-induced constipation, Gastroenterology 156 (2019) 229-253.e5. https://doi.org/10.1053/j.gastro.2018.08.018.

[28]

S. Ghimire, L. Subedi, N. Acharya, et al., Moringa oleifera: a tree of life as a promising medicinal plant for neurodegenerative diseases, J. Agric. Food Chem. 69 (2021) 14358-14371. https://doi.org/10.1021/acs.jafc.1c04581.

[29]

S. Arora, S. Arora. Nutritional significance and therapeutic potential of Moringa oleifera: the wonder plant, J. Food Biochem. 45 (2021) e13933. https://doi.org/10.1111/jfbc.13933.

[30]

J.E. Kim, J.W. Park, M.J. Kang, et al., Laxative effect of spicatoside a by cholinergic regulation of enteric nerve in loperamide-induced constipation: ICR mice model, Molecules 24 (2019) 896. https://doi.org/10.3390/molecules24050896.

[31]

J.E. Kim, M.R. Lee, J.J. Park, et al., Quercetin promotes gastrointestinal motility and mucin secretion in loperamide-induced constipation of SD rats through regulation of the mAChRs downstream signal, Pharm. Biol. 56 (2018) 309-317. https://doi.org/10.1080/13880209.2018.1474932.

[32]

J.Q. Yin, Y.C. Liang, D.L. Wang, et al., Naringenin induces laxative effects by upregulating the expression levels of c-Kit and SCF, as well as those of aquaporin 3 in mice with loperamide-induced constipation, Int. J. Mol. Med. 41 (2018) 649-658. https://doi.org/10.3892/ijmm.2017.3301.

[33]

C. Nogales, Z.M. Mamdouh, et al., Network pharmacology: curing causal mechanisms instead of treating symptoms, Trends Pharmacol. Sci. 43 (2022) 136-150. https://doi.org/10.1016/j.tips.2021.11.004.

[34]

P. Poornima, J.D. Kumar , Q. Zhao, et al., Network pharmacology of cancer: from understanding of complex interactomes to the design of multi-target specific therapeutics from nature, Pharmacol. Res. 111 (2016) 290-302. https://doi.org/10.1016/j.phrs.2016.06.018.

[35]

X. Wang, Z.Y. Wang, J.H. Zheng, et al., TCM network pharmacology: a new trend towards combining computational, experimental and clinical approaches, Chin. J. Nat. Med. 19 (2021) 1-11. https://doi.org/10.1016/S1875-5364(21)60001-8.

[36]

S. Li. Mapping ancient remedies: applying a network approach to traditional Chinese medicine, Science 350 (2015) S72-S74.

[37]

L. Fan, Y. Peng, X.N. Chen, et al., Integrated analysis of phytochemical composition, pharmacokinetics, and network pharmacology to probe distinctions between the stems of Cistanche deserticola and C. tubulosa based on antidepressant activity, Food Funct. 13 (2022) 8542-8557. https://doi.org/10.1039/d2fo01357f.

[38]

P. Li, H.R. Zhang, W.X. Zhang, et al., TMNP: a transcriptome-based multi-scale network pharmacology platform for herbal medicine, Brief. Bioinform. 23 (2022) bbab542. https://doi.org/10.1093/bib/bbab542.

[39]

M. Camilleri, Gastrointestinal motility disorders in neurologic disease, J. Clin. Invest. 131 (2021) e143771. https://doi.org/10.1172/JCI143771.

[40]

B.C. Jin, S.E. Ha, L. Wei, et al., Colonic motility is improved by the activation of 5-HT2B receptors on interstitial cells of cajal in diabetic mice, Gastroenterology 161 (2021) 608-622.e7. https://doi.org/10.1053/j.gastro.2021.04.040.

[41]

H. Wu, Y.J. Chen, B.B. Huang, et al., Aster tataricus alleviates constipation by antagonizing the binding of acetylcholine to muscarinic receptor and inhibiting Ca2+ influx, Biomed. Pharmacother. 133 (2021) 111005. https://doi.org/10.1016/j.biopha.2020.111005.

[42]

C.L. Yang, X.S. Bai, T.J. Hu, et al., Integrated metagenomics and targeted-metabolomics analysis of the effects of phenylalanine on loperamide-induced constipation in rats, Front. Microbiol. 13 (2022) 1018008. https://doi.org/10.3389/fmicb.2022.1018008.

[43]

J.D. Fernstrom, M.H. Fernstrom, Tyrosine, phenylalanine, and catecholamine synthesis and function in the brain, J. Nutr. 137 (2007) 1539S-1547S; 1548S. https://doi.org/10.1093/jn/137.6.1539S.

[44]

Y. Osuga, K. Harada, T. Tsuboi. Identification of a regulatory pathway of L-phenylalanine-induced GLP-1 secretion in the enteroendocrine L cells, Biochem. Biophys. Res. Commun. 588 (2022) 118-124. https://doi.org/10.1016/j.bbrc.2021.12.043.

[45]

G. Song, Q.Y. Gan, W.T. Qi, et al., Fructose stimulated colonic arginine and proline metabolism dysbiosis, altered microbiota and aggravated intestinal barrier dysfunction in DSS-induced colitis rats, Nutrients 15 (2023) 782. https://doi.org/10.3390/nu15030782.

[46]

C. Liu, C.W. Sun, Y.L. Cheng. β-Glucan alleviates mice with ulcerative colitis through interactions between gut microbes and amino acids metabolism, J. Sci. Food Agric. 103 (2022) 4006-4016. https://doi.org/10.1002/jsfa.12357.

[47]

J.L. Owen, S.X. Cheng, Y. Ge, et al., The role of the calcium-sensing receptor in gastrointestinal inflammation, Semin. Cell Dev. Biol. 49 (2016) 44-51. https://doi.org/10.1016/j.semcdb.2015.10.040.

[48]

S.P. Alexander, A. Christopoulos, A.P. Davenport, et al., The concise guide to pharmacology 2021/22: G protein-coupled receptors, Br. J. Pharmacol. 178 (2021) S27-S156. https://doi.org/10.1111/bph.15538.

[49]

M.M. Sun, W. Wu, Z.J. Liu, et al., Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases, J. Gastroenterol. 52 (2017) 1-8. https://doi.org/10.1007/s00535-016-1242-9.

[50]

Y. Bhattarai, B.B. Williams, E.J. Battaglioli, et al., Gut microbiota-produced tryptamine activates an epithelial G-protein-coupled receptor to increase colonic secretion, Cell Host Microbe 23 (2018) 775-785.e5. https://doi.org/10.1016/j.chom.2018.05.004.

[51]

Y.Y. Lu, Z. Yu, Z. Zhang, et al., Bifidobacterium animalis F1-7 in combination with konjac glucomannan improves constipation in mice via humoral transport, Food Funct. 12 (2021) 791-801. https://doi.org/10.1039/d0fo02227f.

[52]

J.J. DiCello, S.E. Carbone, A. Saito, et al., Positive allosteric modulation of endogenous delta opioid receptor signaling in the enteric nervous system is a potential treatment for gastrointestinal motility disorders. Am. J. Physiol. Gastrointest. Liver. Physiol. 322(1) (2022) G66-G78. https://doi.org/10.1152/ajpgi.00297.2021.

[53]

J.Y. Zhang, Y.J. Jiang, H.B. Li, et al., Elevation of HO-1 expression protects the intestinal mucosal barrier in severe acute pancreatitis via inhibition of the MLCK/p-MLC signaling pathway, Exp. Cell Res. 424 (2023) 113508. https://doi.org/10.1016/j.yexcr.2023.113508.

[54]

S.P. Liu, J.Y. Li, W.L. Kang, et al., Aflatoxin B1 induces intestinal barrier dysfunction by regulating the FXR-mediated MLCK signaling pathway in mice and in IPEC-J2 cells, J. Agric. Food Chem. 71 (2023) 867-876. https://doi.org/10.1021/acs.jafc.2c06931.

[55]

H.C. Cui, Q. Wang, C.R. Feng, et al., Positive effect of Bifidobacterium animalis subsp. lactis VHProbi YB11 in improving gastrointestinal movement of mice having constipation, Front. Microbiol. 13 (2022) 1040371. https://doi.org/10.3389/fmicb.2022.1040371.

[56]

W. Zieglgänsberger, Substance P and pain chronicity, Cell Tissue Res. 375 (2019) 227-241. https://doi.org/10.1007/s00441-018-2922-y.

[57]

Y. Lu, Z. Zhang, L. Tong, et al., Mechanisms underlying the promotion of 5-hydroxytryptamine secretion in enterochromaffin cells of constipation mice by Bifidobacterium and Lactobacillus, Neurogastroenterol. Motil. 33 (2021) e14082. https://doi.org/10.1111/nmo.14082.

[58]

S.M. Heissler, J.R. Sellers, Myosin light chains: teaching old dogs new tricks, Bioarchitecture 4 (2014) 169-188. https://doi.org/10.1080/19490992.2015.1054092.

[59]

C.H. Huang, J. Schuring, J.P. Skinner, et al., MYL9 deficiency is neonatal lethal in mice due to abnormalities in the lung and the muscularis propria of the bladder and intestine, PLoS One 17 (2022) e0270820. https://doi.org/10.1371/journal.pone.0270820.

[60]

B. Deb, D.O. Prichard, A.E. Bharucha, Constipation and fecal incontinence in the elderly, Curr. Gastroenterol. Rep. 22 (2020) 54. https://doi.org/10.1007/s11894-020-00791-1.

[61]

L.X. Zhai, C.H. Huang, Z.W. Ning, et al., Ruminococcus gnavus plays a pathogenic role in diarrhea-predominant irritable bowel syndrome by increasing serotonin biosynthesis, Cell Host Microbe 31 (2023) 33-44.e5. https://doi.org/10.1016/j.chom.2022.11.006.

Food Science and Human Wellness
Article number: 9250059
Cite this article:
Li S, Gao X, Guo K, et al. Exploring the material basis and mechanism of Moringa oleifera in alleviating slow transit constipation based on network pharmacology and animal models. Food Science and Human Wellness, 2025, 14(3): 9250059. https://doi.org/10.26599/FSHW.2024.9250059
Metrics & Citations  
Article History
Copyright
Rights and Permissions
Return